Stride (NYSE:LRN) Stock, Quote.Headers.trade-ideas

Stride

Stride Inc is an American online educational company. It offers alternative programs to traditional on-campus schooling. It also operates state-funded virtual charter schools around the United States. The educational programs for K-12 students are usually monitored by parents and provide virtual classroom environments where teachers meet with students online, by phone, or in-person. The company's contractual agreements with various school districts to offer its curriculum programs provide a majority of the company's revenue. The company lines of business are Managed Public School Programs, Institutional, and Private Pay Schools and Other.

Hims & Hers Health, Inc. Class A Common Stock

HIMS

MPWR

NVDA

VICR


Every earnings season has its share of winners and losers, as well as top and bottom-line surprises and disappointments. This recent earnings season is no different. Investors are always curious about the best

4 Stocks That Crushed Analyst Estimates by More Than Double


Short sellers are market bears that seek to profit from falling stock prices. Some of the more popular short sellers will put out their research reports attempting to expose a target company by implying misconduct or

2 Stocks That Crushed Short Sellers With Impressive Gains

Stride Inc

NYLI U.S. Large Cap R&D Leaders ETF

TrueShares Technology, AI & Deep Learning ETF

<h3>Gainers</h3>
<ul>
<li>Soho House (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SHCO#NYSE">SHCO</a>) shares moved upwards by 61.9% to $7.95 during Thursday's pre-market session. The company's market cap stands at $1.5 billion. As per the news, the Q3 earnings report came out today. </li>
<li>Foresight Autonomous (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FRSX#NASDAQ">FRSX</a>) shares rose 24.99% to $1.15. The company's market cap stands at $17.6 million. </li>
<li>Sacks Parente Golf (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPGC#NASDAQ">SPGC</a>) shares increased by 16.66% to $0.35. </li>
<li>Charles &amp; Colvard (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTHR#NASDAQ">CTHR</a>) shares increased by 15.78% to $1.54. The market value of their outstanding shares is at $4.7 million. </li>
<li>Sypris Solutions (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SYPR#NASDAQ">SYPR</a>) shares rose 14.22% to $2.57. The market value of their outstanding shares is at $59.1 million. </li>
<li>Zapp Electric Vehicles (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZAPP#NASDAQ">ZAPP</a>) shares rose 12.41% to $1.63. The market value of their outstanding shares is at $6.8 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>ZHONGCHAO (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZCMD#NASDAQ">ZCMD</a>) shares declined by 11.8% to $1.78 during Thursday's pre-market session. The market value of their outstanding shares is at $44.8 million. </li>
<li>Lixiang Education Hldg (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LXEH#NASDAQ">LXEH</a>) shares declined by 8.22% to $3.13. The company's market cap stands at $3.6 million. </li>
<li>Algorhythm Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RIME#NASDAQ">RIME</a>) shares declined by 8.15% to $0.09. The market value of their outstanding shares is at $1.6 million. </li>
<li>Lennar (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LEN#NYSE">LEN</a>) stock fell 7.77% to $134.6. The company's market cap stands at $36.9 billion. The company's, Q4 earnings came out yesterday. </li>
<li>Stride (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LRN#NYSE">LRN</a>) shares decreased by 7.43% to $97.47. The company's market cap stands at $4.2 billion. </li>
<li>Fitell (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTEL#NASDAQ">FTEL</a>) stock decreased by 6.29% to $6.56. The market value of their outstanding shares is at $131.8 million. 
See Also: <a href="http://www.benzinga.com/money/best-consumer-cyclical-stocks/" title="www.benzinga.com/money/best-consumer-cyclical-stocks/">www.benzinga.com/money/best-consumer-cyclical-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Movers

CTHR

FRSX

FTEL

LXEH

RIME

SHCO

SPGC

SYPR

ZAPP

ZCMD

12 Consumer Discretionary Stocks Moving In Thursday's Pre-Market Session

In the last three months, 7 analysts have published ratings on Stride (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LRN#NYSE">LRN</a>), offering a diverse range of perspectives from bullish to bearish.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">1</td>
<td align="right">4</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $95.86, a high estimate of $109.00, and a low estimate of $88.00. Surpassing the previous average price target of $90.29, the current average has increased by 6.17%.
<img src="https://www.benzinga.com/files/images/story/2024/1734026434_0.png" alt="price target chart" />
<h2>Decoding Analyst Ratings: A Detailed Look</h2>
A clear picture of Stride's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Greg Parrish</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$109.00</td>
<td>$94.00</td>
</tr>
<tr>
<td>Thomas Singlehurst</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Neutral</td>
<td>$94.00</td>
<td>$90.00</td>
</tr>
<tr>
<td>Jeffrey Silber</td>
<td>BMO Capital</td>
<td>Raises</td>
<td>Outperform</td>
<td>$88.00</td>
<td>$84.00</td>
</tr>
<tr>
<td>Alexander Paris</td>
<td>Barrington Research</td>
<td>Raises</td>
<td>Outperform</td>
<td>$100.00</td>
<td>$90.00</td>
</tr>
<tr>
<td>Jason Tilchen</td>
<td>Canaccord Genuity</td>
<td>Raises</td>
<td>Buy</td>
<td>$100.00</td>
<td>$94.00</td>
</tr>
<tr>
<td>Alexander Paris</td>
<td>Barrington Research</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$90.00</td>
<td>$90.00</td>
</tr>
<tr>
<td>Alexander Paris</td>
<td>Barrington Research</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$90.00</td>
<td>$90.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Stride. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of Stride compared to the broader market.</li>
<li>Price Targets: Analysts predict movements in price targets, offering estimates for Stride's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into Stride's market standing. Stay informed and make well-considered decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/LRN/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Stride analyst ratings.</a>
<h2>Delving into Stride's Background</h2>
Stride Inc is an American online educational company. It offers alternative programs to traditional on-campus schooling. It also operates state-funded virtual charter schools around the United States. The educational programs for K-12 students are usually monitored by parents and provide virtual classroom environments where teachers meet with students online, by phone, or in-person. The company's contractual agreements with various school districts to offer its curriculum programs provide a majority of the company's revenue. The company lines of business are Managed Public School Programs, Institutional, and Private Pay Schools and Other.
<h3>Stride's Financial Performance</h3>
Market Capitalization Analysis: With a profound presence, the company's market capitalization is above industry averages. This reflects substantial size and strong market recognition.
Revenue Growth: Stride's revenue growth over a period of 3 months has been noteworthy. As of 30 September, 2024, the company achieved a revenue growth rate of approximately 14.77%. This indicates a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Consumer Discretionary sector.
Net Margin: Stride's net margin is impressive, surpassing industry averages. With a net margin of 7.42%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): Stride's ROE excels beyond industry benchmarks, reaching 3.42%. This signifies robust financial management and efficient use of shareholder equity capital.
Return on Assets (ROA): Stride's ROA excels beyond industry benchmarks, reaching 2.1%. This signifies efficient management of assets and strong financial health.
Debt Management: Stride's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.46.
<h2>Analyst Ratings: What Are They?</h2>
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.
Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.
Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Analyst Ratings

Expert Ratings For Stride

Morgan Stanley analyst Greg Parrish maintains Stride (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LRN#NYSE">LRN</a>) with a Equal-Weight and raises the price target from $94 to $109.

News

Price Target

Morgan Stanley Maintains Equal-Weight on Stride, Raises Price Target to $109

Citigroup analyst Thomas Singlehurst maintains Stride (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LRN#NYSE">LRN</a>) with a Neutral and raises the price target from $90 to $94.

Citigroup Maintains Neutral on Stride, Raises Price Target to $94

On October 28, a recent SEC filing unveiled that Todd Goldthwaite, Managing Director at Stride (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LRN#NYSE">LRN</a>) made an insider sell.
What Happened: According to a Form 4 filing with the <a href="https://www.sec.gov/Archives/edgar/data/0001157408/000110465924111868//Archives/edgar/data/1157408/000110465924111868/0001104659-24-111868-index.htm">U.S. Securities and Exchange Commission</a> on Monday, Goldthwaite sold 8,028 shares of Stride. The total transaction value is $734,918.
Monitoring the market, Stride's shares down by 0.55% at $90.5 during Tuesday's morning.
<h3>Discovering Stride: A Closer Look</h3>
Stride Inc is an American online educational company. It offers alternative programs to traditional on-campus schooling. It also operates state-funded virtual charter schools around the United States. The educational programs for K-12 students are usually monitored by parents and provide virtual classroom environments where teachers meet with students online, by phone, or in-person. The company's contractual agreements with various school districts to offer its curriculum programs provide a majority of the company's revenue. The company lines of business are Managed Public School Programs, Institutional, and Private Pay Schools and Other.
<h3>Stride: Delving into Financials</h3>
Revenue Growth: Stride displayed positive results in 3 months. As of 30 September, 2024, the company achieved a solid revenue growth rate of approximately 14.77%. This indicates a notable increase in the company's top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Consumer Discretionary sector.
Interpreting Earnings Metrics:
<ul>
<li>
Gross Margin: With a low gross margin of 39.17%, the company exhibits below-average profitability, signaling potential struggles in cost efficiency compared to its industry peers.
</li>
<li>
Earnings per Share (EPS): Stride's EPS is notably higher than the industry average. The company achieved a positive bottom-line trend with a current EPS of 0.95.
</li>
</ul>
Debt Management: With a below-average debt-to-equity ratio of 0.46, Stride adopts a prudent financial strategy, indicating a balanced approach to debt management.
Market Valuation:
<ul>
<li>
Price to Earnings (P/E) Ratio: With a lower-than-average P/E ratio of 16.49, the stock indicates an attractive valuation, potentially presenting a buying opportunity.
</li>
<li>
Price to Sales (P/S) Ratio: The P/S ratio of 1.88 is lower than the industry average, implying a discounted valuation for Stride's stock in relation to sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): With a below-average EV/EBITDA ratio of 9.23, Stride presents an opportunity for value investors. This lower valuation may attract investors seeking undervalued opportunities.
</li>
</ul>
Market Capitalization: Exceeding industry standards, the company's market capitalization places it above industry average in size relative to peers. This emphasizes its significant scale and robust market position.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>Uncovering the Importance of Insider Activity</h3>
Considering insider transactions is valuable, but it's crucial to evaluate them in conjunction with other investment factors.
In the context of legal matters, the term "insider" refers to any officer, director, or beneficial owner holding more than ten percent of a company's equity securities, as outlined by Section 12 of the Securities Exchange Act of 1934. This includes executives in the c-suite and significant hedge funds. Such insiders are obligated to report their transactions through a Form 4 filing, which must be completed within two business days of the transaction.
Pointing towards optimism, a company insider's new purchase signals their positive anticipation for the stock to rise.
Despite insider sells not always signaling a bearish sentiment, they can be driven by various factors.
<h3>A Closer Look at Important Transaction Codes</h3>
Examining transactions, <a href="https://www.benzinga.com/money/investing-tools">investors</a> often concentrate on those unfolding in the open market, meticulously detailed in Table I of the Form 4 filing. A P in Box 3 denotes a purchase, while S signifies a sale. Transaction code C indicates the conversion of an option, and transaction code A denotes a grant, award, or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0001157408">Check Out The Full List Of Stride's Insider Trades.</a>
Insider Buying Alert: Profit from C-Suite Moves
Benzinga Edge reveals every insider trade in real-time. Don't miss the next big stock move driven by insider confidence. Unlock this ultimate sentiment indicator now. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22in8&amp;utm_source=benzinga-insights">Click here for access</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Insider Trades

Trading Ideas

Massive Insider Trade At Stride

These ten mid-cap stocks were the best performers in the last week. Are they in your portfolio?
<ol>
<li>ImmunityBio, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IBRX#NASDAQ">IBRX</a>) stock upped 49.86% after the company announced it dosed its first patients in its Phase 1 clinical study of CAR-NK cell therapy for relapsed <a href="https://www.benzinga.com//node/41516867" target="_blank" rel="noreferrer noopener">B-Cell Non-Hodgkin Lymphoma</a>.</li>
<li>Stride, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LRN#NYSE">LRN</a>) shares rocketed 41.43% after the company reported better-than-expected first-quarter results and issued FY25 and second-quarter <a href="https://www.benzinga.com//node/41487340" target="_blank" rel="noreferrer noopener">revenue guidance above estimates</a>. Analysts boosted the <a href="https://www.benzinga.com/quote/lrn/analyst-ratings" target="_blank" rel="noreferrer noopener">price target on the stock</a>.</li>
<li>PureCycle Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PCT#NASDAQ">PCT</a>) <a href="https://www.benzinga.com//node/41409452" target="_blank" rel="noreferrer noopener">shares jumped 32.21%</a>.</li>
<li>Trump Media &amp; Technology Group Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DJT#NASDAQ">DJT</a>) stock gained 31.68% last week. The stock has been volatile ahead of the upcoming U.S. election.</li>
<li>ZEEKR Intelligent Technology (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZK#NYSE">ZK</a>) gained 29.31%. Several U.S.-listed Chinese stocks gained after the People's Bank of China <a href="https://www.benzinga.com//node/41547149" target="_blank" rel="noreferrer noopener">injected 700 billion yuan</a> ($98.36 billion) into the banking system through its one-year medium-term lending facility, keeping the rate steady at 2.0%.</li>
<li>IonQ, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IONQ#NYSE">IONQ</a>) stock gained 27.52%.</li>
<li>Herc Holdings Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HRI#NYSE">HRI</a>) shares upped 21.76% after the company reported better-than-expected third-quarter revenue results and raised its FY24 equipment <a href="https://www.benzinga.com//node/41455862" target="_blank" rel="noreferrer noopener">rental revenue growth outlook</a>.</li>
<li>TeraWulf Inc.'s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WULF#NASDAQ">WULF</a>) stock gained 18.59% amid the rise in Bitcoin's (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) price. The company also proposed to raise $425 million via convertible senior debt notes.</li>
<li>iRhythm Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IRTC#NASDAQ">IRTC</a>) stock escalated 20.76% after the company announced that it was granted FDA clearance for its 510(k) submission related to prior design changes <a href="https://www.benzinga.com//node/41462205" target="_blank" rel="noreferrer noopener">made to the Zio AT device</a>.</li>
<li>Celestica, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLS#NYSE">CLS</a>) shares rose 19.99% after the company reported better-than-expected third-quarter results and issued Q4 revenue guidance above estimates. Several analysts raised <a href="https://www.benzinga.com//node/41523564" target="_blank" rel="noreferrer noopener">the price target on the stock</a>.</li>
</ol>
Also Read:
<ul>
<li><a href="https://www.benzinga.com/news/large-cap/24/10/41560908/tesla-li-auto-and-microstrategy-are-among-top-10-large-cap-gainers-last-week-oct-21-oct-25-are-the" target="_blank" rel="noreferrer noopener">Tesla, Li Auto And MicroStrategy Are Among Top 10 Large Cap Gainers Last Week (Oct 21-Oct 25): Are The Others In Your Portfolio?</a></li>
<li><a href="https://www.benzinga.com/news/large-cap/24/10/41561358/genuine-parts-company-universal-health-services-and-topbuild-are-among-top-10-large-cap-losers-las" target="_blank" rel="noreferrer noopener">Genuine Parts Company, Universal Health Services, And TopBuild Are Among Top 10 Large Cap Losers Last Week (Oct 21-Oct 25): Are The Others In Your Portfolio?</a></li>
</ul>
Photo via Shutterstock

Mid Cap

$BTC

IBRX

IONQ

IRTC

WULF

Trump Media & Tech, ImmunityBio, And iRhythm Are Among Top 10 Mid Cap Gainers Last Week (Oct 21-Oct 25): Are The Others In Your Portfolio?

Stride's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LRN#NYSE">LRN</a>) short percent of float has risen 24.01% since its last report. The company recently reported that it has 7.29 million shares sold short, which is 23.5% of all regular shares that are available for trading. Based on its trading volume, it would take traders 7.33 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Stride Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1729872918_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Stride has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Stride's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Stride's peer group average for short interest as a percentage of float is 4.74%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

How Is The Market Feeling About Stride?

BMO Capital analyst Jeffrey Silber maintains Stride (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LRN#NYSE">LRN</a>) with a Outperform and raises the price target from $84 to $88.

BMO Capital Maintains Outperform on Stride, Raises Price Target to $88

Barrington Research analyst Alexander Paris maintains Stride (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LRN#NYSE">LRN</a>) with a Outperform and raises the price target from $90 to $100.

Barrington Research Maintains Outperform on Stride, Raises Price Target to $100

<h3>Gainers</h3>
<ul>
<li>Stride (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LRN#NYSE">LRN</a>) stock moved upwards by 34.4% to $86.69 during Wednesday's regular session. The market value of their outstanding shares is at $3.7 billion. As per the news, the Q1 earnings report came out yesterday. </li>
<li>Pinstripes Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PNST#NYSE">PNST</a>) shares rose 30.98% to $0.93. The market value of their outstanding shares is at $47.3 million. </li>
<li>Jiade (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JDZG#NASDAQ">JDZG</a>) stock moved upwards by 26.49% to $1.48. The market value of their outstanding shares is at $36.1 million. </li>
<li>Mingteng International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MTEN#NASDAQ">MTEN</a>) shares moved upwards by 21.1% to $7.14. The market value of their outstanding shares is at $44.3 million. </li>
<li>Lithia Motors (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LAD#NYSE">LAD</a>) stock moved upwards by 10.24% to $335.75. The company's market cap stands at $8.9 billion. As per the press release, Q3 earnings came out today. </li>
<li>Star Equity Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STRRP#NASDAQ">STRRP</a>) stock increased by 8.69% to $10.25. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Interactive Strength (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRNR#NASDAQ">TRNR</a>) shares fell 15.8% to $0.15 during Wednesday's regular session. </li>
<li>Uxin (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UXIN#NASDAQ">UXIN</a>) shares declined by 13.64% to $4.75. The company's market cap stands at $892.7 million. </li>
<li>Digital Brands Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DBGI#NASDAQ">DBGI</a>) stock fell 13.26% to $0.32. The company's market cap stands at $1.2 million. </li>
<li>Alta Global Group (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/MMA#AMEX">MMA</a>) stock declined by 12.98% to $1.81. The company's market cap stands at $18.9 million. </li>
<li>JX Luxventure (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JXJT#NASDAQ">JXJT</a>) shares fell 12.74% to $1.37. The market value of their outstanding shares is at $8.3 million. </li>
<li>Mullen Automotive (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MULN#NASDAQ">MULN</a>) shares decreased by 12.21% to $2.59. The market value of their outstanding shares is at $14.4 million. 
See Also: <a href="http://www.benzinga.com/money/best-consumer-cyclical-stocks/" title="www.benzinga.com/money/best-consumer-cyclical-stocks/">www.benzinga.com/money/best-consumer-cyclical-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

DBGI

JDZG

JXJT

MTEN

MULN

PNST

STRRP

TRNR

UXIN

12 Consumer Discretionary Stocks Moving In Wednesday's Intraday Session

U.S. stocks were lower, with the Dow Jones index falling around 200 points on Wednesday.
Shares of Texas Instruments Incorporated (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TXN#NASDAQ">TXN</a>) rose sharply during Wednesday's session following <a href="https://www.benzinga.com/quote/TXN/earnings">better-than-expected third-quarter financial results.</a>
Texas Instruments reported quarterly earnings of $1.47 per share, which beat the analyst consensus estimate of $1.37. Quarterly revenue of $4.151 billion beat the consensus estimate of $4.12 billion.
Texas Instruments shares surged 4.3% to $202.30 on Wednesday.
Here are some other big stocks recording gains in today's session.
<ul>
<li>Stride, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LRN#NYSE">LRN</a>) shares climbed 31% to $84.49 after the company reported better-than-expected first-quarter financial results and issued FY25 and Q2 revenue guidance above estimates.</li>
<li>Upwork Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UPWK#NASDAQ">UPWK</a>) gained 24.4% to $12.50 after the company reported preliminary third-quarter revenue guidance above estimates. Also, the company announced organizational changes including a workforce reduction.</li>
<li>Vicor Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VICR#NASDAQ">VICR</a>) gained 18.3% to $51.43 after the company reported better-than-expected third-quarter financial results.</li>
<li>John Bean Technologies Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JBT#NYSE">JBT</a>) surged 11.7% to $106.36 after the company reported better-than-expected third-quarter adjusted EPS and sales.</li>
<li>Valmont Industries, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VMI#NYSE">VMI</a>) gained 10.6% to $326.14 following upbeat quarterly earnings.</li>
<li>Daqo New Energy Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DQ#NYSE">DQ</a>) climbed 8.9% to $22.67.</li>
<li>Lithia Motors, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LAD#NYSE">LAD</a>) gained 8.9% to $331.58 following better-than-expected quarterly earnings.</li>
<li>Northern Trust Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTRS#NASDAQ">NTRS</a>) surged 7.5% to $103.00 after the company reported better-than-expected quarterly financial results.</li>
<li>East West Bancorp, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EWBC#NASDAQ">EWBC</a>) rose 7.5% to $97.14 following upbeat earnings.</li>
<li>Packaging Corporation of America (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PKG#NYSE">PKG</a>) gained 5.8% to $229.32 after the company reported better-than-expected quarterly financial results.</li>
<li>Renasant Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RNST#NYSE">RNST</a>) surged 5.5% to $34.25 following strong quarterly results.</li>
<li>ImmunityBio, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IBRX#NASDAQ">IBRX</a>) gained 5% to $3.6600. EF Hutton analyst Jason Kolbert initiated coverage on ImmunityBio with a Buy rating and announced a price target of $30.</li>
<li>Teledyne Technologies Incorporated (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TDY#NYSE">TDY</a>) gained 4.2% to $461.94 after reporting strong quarterly earnings.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/10/41485836/how-to-earn-500-a-month-from-ibm-stock-ahead-of-q3-earnings">How To Earn $500 A Month From IBM Stock Ahead Of Q3 Earnings</a></li>
</ul>

Intraday Update

Markets

EWBC

NTRS

RNST

UPWK

Texas Instruments Posts Strong Q3 Results, Joins Valmont Industries, Lithia Motors, Teledyne Technologies And Other Big Stocks Moving Higher On Wednesday

Stride, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LRN#NYSE">LRN</a>) shares are rocketing premarket today after it reported first-quarter results on Tuesday. Revenue improved 14.8% year-over-year to $551.1 million, beating the <a target="_blank" href="https://www.benzinga.com/pressreleases/24/10/g41466281/strong-demand-drives-record-enrollment" rel="noreferrer noopener">consensus of $506.1 million</a>.
Adjusted operating income&nbsp;escalated 295.4% to $58.360 million. Adjusted EBITDA increased 111.1% to $83.93 million.
Enrollments reached 222.6K, an increase of 18.5% on year. Of this, career Learning enrollments accounted for 91.7K, up 30.4% over prior year.
Revenue per enrollment was $2,303, a 0.5% growth over the prior year. General Education revenue per enrollment rose 0.8% to $2,400, while Career Learning revenue per enrollment increased 1.0% to $2,166.
Changes in enrollment mix may impact total revenue if averages differ significantly. EPS of $0.94&nbsp;<a target="_blank" href="https://www.benzinga.com/earnings" rel="noreferrer noopener">beat the consensus of $0.20</a>.
As of September 30, cash, cash equivalents, and marketable securities totaled $539.4 million.
Outlook: Stride expects second-quarter sales of $560 million &#8211; $580 million (vs. consensus of $535.35 million) and adjusted operating <a href="https://www.benzinga.com/calendars/guidance" target="_blank" rel="noreferrer noopener">income of $115 million &#8211; $125 million</a>.
For FY25, the company projects sales of $2.225 billion &#8211; $2.300 billion (vs.&nbsp;estimate of $2.17 billion) and adjusted operating income of $395 million &#8211; $425 million.
Price Action: LRN shares are up 26.85% at $81.77 premarket at the last check Wednesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com//node/41481122" target="_blank" rel="noreferrer noopener">GM &#8216;Working Hard&#8217; To Resume Driverless Cruise Vehicles By End Of Year, Says CEO Mary Barra: &#8216;We Want To Make Sure We&#8217;re Investing In Autonomy As Efficiently As Possible&#8217;</a></li>
</ul>

Earnings

Equities

Large Cap

Guidance

Stride Rockets On Q1 Results: Enrollments Up 18.5%, EPS Smashes Estimates

<h3>Gainers</h3>
<ul>
<li>Stride (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LRN#NYSE">LRN</a>) stock moved upwards by 24.1% to $80.01 during Wednesday's pre-market session. The market value of their outstanding shares is at $3.4 billion. The company's, Q1 earnings came out yesterday. </li>
<li>Foresight Autonomous (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FRSX#NASDAQ">FRSX</a>) stock increased by 11.79% to $0.73. The company's market cap stands at $11.1 million. </li>
<li>Alta Global Group (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/MMA#AMEX">MMA</a>) shares increased by 9.61% to $2.28. The market value of their outstanding shares is at $23.8 million. </li>
<li>Jianzhi Education Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JZ#NASDAQ">JZ</a>) stock moved upwards by 8.57% to $1.14. The company's market cap stands at $23.0 million. </li>
<li>Pinstripes Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PNST#NYSE">PNST</a>) shares rose 7.0% to $0.76. The company's market cap stands at $38.6 million. </li>
<li>Vision Marine (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VMAR#NASDAQ">VMAR</a>) stock rose 5.95% to $4.03. The market value of their outstanding shares is at $2.2 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Digital Brands Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DBGI#NASDAQ">DBGI</a>) stock fell 18.6% to $0.3 during Wednesday's pre-market session. The market value of their outstanding shares is at $1.1 million. </li>
<li>SRM Entertainment (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SRM#NASDAQ">SRM</a>) stock fell 10.27% to $0.84. The market value of their outstanding shares is at $10.0 million. </li>
<li>Winnebago Industries (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WGO#NYSE">WGO</a>) stock fell 8.66% to $53.0. The market value of their outstanding shares is at $1.5 billion. As per the press release, Q4 earnings came out today. </li>
<li>Autozi Internet Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AZI#NASDAQ">AZI</a>) stock fell 8.37% to $0.82. The market value of their outstanding shares is at $86.0 million. </li>
<li>Jowell Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JWEL#NASDAQ">JWEL</a>) stock declined by 7.81% to $1.89. The company's market cap stands at $4.1 million. </li>
<li>McDonald's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MCD#NYSE">MCD</a>) shares decreased by 6.59% to $293.96. The company's market cap stands at $211.8 billion. 
See Also: <a href="http://www.benzinga.com/money/best-consumer-cyclical-stocks/" title="www.benzinga.com/money/best-consumer-cyclical-stocks/">www.benzinga.com/money/best-consumer-cyclical-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

JWEL

VMAR

12 Consumer Discretionary Stocks Moving In Wednesday's Pre-Market Session

<h3>Gainers</h3>
<ul>
<li>Stride (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LRN#NYSE">LRN</a>) stock moved upwards by 24.1% to $80.01 during Wednesday's pre-market session. The market value of their outstanding shares is at $3.4 billion. As per the news, the Q1 earnings report came out yesterday. </li>
<li>Foresight Autonomous (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FRSX#NASDAQ">FRSX</a>) stock moved upwards by 11.79% to $0.73. The company's market cap stands at $11.1 million. </li>
<li>Alta Global Group (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/MMA#AMEX">MMA</a>) stock rose 9.61% to $2.28. The company's market cap stands at $23.8 million. </li>
<li>Jianzhi Education Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JZ#NASDAQ">JZ</a>) shares rose 8.57% to $1.14. The company's market cap stands at $23.0 million. </li>
<li>Pinstripes Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PNST#NYSE">PNST</a>) stock rose 7.0% to $0.76. The market value of their outstanding shares is at $38.6 million. </li>
<li>Vision Marine (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VMAR#NASDAQ">VMAR</a>) shares increased by 5.95% to $4.03. The company's market cap stands at $2.2 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Digital Brands Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DBGI#NASDAQ">DBGI</a>) shares fell 18.6% to $0.3 during Wednesday's pre-market session. The market value of their outstanding shares is at $1.1 million. </li>
<li>SRM Entertainment (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SRM#NASDAQ">SRM</a>) shares declined by 10.27% to $0.84. The market value of their outstanding shares is at $10.0 million. </li>
<li>Winnebago Industries (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WGO#NYSE">WGO</a>) stock declined by 8.66% to $53.0. The company's market cap stands at $1.5 billion. As per the press release, Q4 earnings came out today. </li>
<li>Autozi Internet Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AZI#NASDAQ">AZI</a>) shares decreased by 8.37% to $0.82. The market value of their outstanding shares is at $86.0 million. </li>
<li>Jowell Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JWEL#NASDAQ">JWEL</a>) stock declined by 7.81% to $1.89. The market value of their outstanding shares is at $4.1 million. </li>
<li>McDonald's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MCD#NYSE">MCD</a>) shares decreased by 6.59% to $293.96. The market value of their outstanding shares is at $211.8 billion. 
See Also: <a href="http://www.benzinga.com/money/best-consumer-cyclical-stocks/" title="www.benzinga.com/money/best-consumer-cyclical-stocks/">www.benzinga.com/money/best-consumer-cyclical-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

MCD: -10% &#x7C; <a href="https://www.benzinga.com//node/41484114">McDonald's shares are trading lower following CDC reports of an E. coli outbreak linked to quarter pounders.</a>
&nbsp;
ENPH: -16% &#x7C; <a href="https://www.benzinga.com//node/41484240">Enphase Energy shares are trading lower after the company reported worse-than-expected Q3 financial results.</a>
&nbsp;
LRN: 30% &#x7C; <a href="https://www.benzinga.com//node/41484796">Stride shares are trading higher after the company reported better-than-expected Q1 financial results and issued FY25 and Q2 revenue guidance above estimates.</a>

ENPH

Market-Moving News for October 23rd

WIIM

Stride shares are trading higher after the company reported better-than-expected Q1 financial results and issued FY25 and Q2 revenue guidance above estimates.

Canaccord Genuity analyst Jason Tilchen maintains Stride (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LRN#NYSE">LRN</a>) with a Buy and raises the price target from $94 to $100.

Canaccord Genuity Maintains Buy on Stride, Raises Price Target to $100

Shares of Stride, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LRN#NYSE">LRN</a>) rose sharply in today's pre-market trading after the company reported better-than-expected first-quarter financial results and issued FY25 revenue <a href="https://www.benzinga.com/quote/LRN">guidance above estimates</a>.
Stride reported quarterly earnings of 94 cents per share which beat the analyst consensus estimate of 20 cents per share. The company reported quarterly sales of $551.084 million which beat the analyst consensus estimate of $506.081 million.
Stride shares jumped 24.3% to $80.25 in the pre-market trading session.
Here are some other stocks moving in pre-market trading.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>CNS Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNSP#NASDAQ">CNSP</a>) rose 99.4% to $0.3124 in pre-market trading after jumping around 7% on Tuesday.</li>
<li>DBV Technologies S.A. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DBVT#NASDAQ">DBVT</a>) gained 75.7% to $1.23 in pre-market trading as the company announced positive regulatory updates for the Viaskin&#xAE; Peanut Patch in the United States and Europe.</li>
<li>Mustang Bio, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MBIO#NASDAQ">MBIO</a>) shares surged 60.6% to $0.4531 in pre-market trading after declining around 4% on Tuesday.</li>
<li>Farmmi, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FAMI#NASDAQ">FAMI</a>) rose 55.2% to $0.4890 in pre-market trading after gaining 4% on Tuesday.</li>
<li>Zapata Computing Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZPTA#NASDAQ">ZPTA</a>) shares rose 39.6% to $0.0885 in pre-market trading after dipping around 18% on Tuesday.</li>
<li>ShiftPixy, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PIXY#NASDAQ">PIXY</a>) shares jumped 30.3% to $10.67 in pre-market trading. ShiftPixy signed a LOI to acquire AI innovator TurboScale in a $150 million deal.</li>
<li>Phunware, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PHUN#NASDAQ">PHUN</a>) climbed 23.4% to $14.37 in pre-market trading after jumping 38% on Tuesday.</li>
<li>22nd Century Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XXII#NASDAQ">XXII</a>) gained 19.3% to $0.1387 in pre-market trading after gaining over 10% on Tuesday.</li>
<li>Daqo New Energy Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DQ#NYSE">DQ</a>) shares rose 15.8% to $24.10 in pre-market trading. Daqo New Energy will release its unaudited financial results for the third quarter before the opening bell on Wednesday, Oct. 30.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>Alto Neuroscience, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ANRO#NYSE">ANRO</a>) shares dipped 61.4% to $5.59 in pre-market trading after the company announced topline results from a Phase 2b trial evaluating ALTO-100 as a treatment for major depressed disorder did not meet its primary endpoint.</li>
<li>Genprex, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GNPX#NASDAQ">GNPX</a>) shares fell 20.9% to $2.84 in pre-market trading after jumping around 138% on Tuesday.</li>
<li>Ensysce Biosciences, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENSC#NASDAQ">ENSC</a>) fell 19.3% to $0.4351 in pre-market trading after jumping 162% on Tuesday.</li>
<li>Digital Brands Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DBGI#NASDAQ">DBGI</a>) fell 18.8% to $0.2973 in today's pre-market trading after jumping around 50% on Tuesday.</li>
<li>Neo-Concept International Group Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NCI#NASDAQ">NCI</a>) fell 18.2% to $0.7233 in pre-market trading after dipping 37% on Tuesday.</li>
<li>Chanson International Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CHSN#NASDAQ">CHSN</a>) shares fell 17.2% to $9.92 in pre-market trading.</li>
<li>Enphase Energy, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENPH#NASDAQ">ENPH</a>) declined 15.2% to $78.21 in pre-market trading after the company reported worse-than-expected third-quarter financial results.</li>
<li>Aptevo Therapeutics Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APVO#NASDAQ">APVO</a>) shares declined 14.3% to $0.3023 in pre-market trading after gaining over 48% on Tuesday.</li>
<li>XBP Europe Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XBP#NASDAQ">XBP</a>) shares declined 11.9% to $1.18 in pre-market trading.</li>
<li>McDonald&#8217;s Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MCD#NYSE">MCD</a>) shares fell 7.2% to $292.20 following CDC reports of an E. coli outbreak linked to quarter pounders.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/10/41479244/dow-edges-lower-as-investors-watch-earnings-reports-with-caution-fear-index-remains-in-greed-zone">Dow Edges Lower As Investors Watch Earnings Reports With Caution: Fear Index Remains In &#8216;Greed&#8217; Zone</a></li>
</ul>

Pre-Market Outlook

ANRO

APVO

CHSN

CNSP

DBVT

ENSC

FAMI

GNPX

MBIO

PHUN

PIXY

XXII

ZPTA

Why Stride Shares Are Trading Higher By Over 24%; Here Are 20 Stocks Moving Premarket

Stride (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LRN#NYSE">LRN</a>) sees FY2025 sales of $2.225 billion-2.300 billion vs $2.17 billion estimate.

Stride Sees FY2025 Sales $2.225B-2.300B vs $2.17B Est.

Stride: Full Steam Ahead

Citi raised the firm's price target on Stride (LRN) to $94 from $90 and keeps a Neutral rating on the shares. The firm updated its model to reflect...

Stride price target raised to $94 from $90 at Citi

Invesco Small Cap Growth Fund Q3 2024 Commentary

Janus Henderson Venture Fund Q3 2024 Commentary

Stride: Is Valuation Now A Risk?

Nerdy: A Combination Of Strong Financials, Strategic Shift And Niche Opportunity At Discount

Morgan Stanley analyst Greg Parrish maintained a Hold rating on Stride (LRN – Research Report) today and set a price target of $109.00. The company...

Morgan Stanley Sticks to Its Hold Rating for Stride (LRN)

Morgan Stanley raised the firm's price target on Stride (LRN) to $109 from $94 and keeps an Equal Weight rating on the shares. With potential for i...

Stride price target raised to $109 from $94 at Morgan Stanley

Stride: Industry Winds Are Changing, Uncertainties Abound

American Century Small Cap Growth Fund Q3 2024 Commentary

AAON

ADMA

APEI

ASTS

ASTSW

AVDX

AZEK

BKLN

BLKB

BOOT

CGJTF

CHGG

COHR

COUR

CQQQ

CWST

DSGX

FBIN

FROG

GMED

GWRE

ICUI

ITGR

KBWB

KBWD

KBWY

LAUR

LPLA

NRDY

NSSC

NTRA

OLLI

PCEF

PCVX

PDBC

PNQI

PRFZ

PRMFF

PYFRF

QQQJ

QQQM

QTWO

RKLIF

RPAY

RSPT

SITE

SONO

SOXQ

SPGP

SPHB

SPHD

SPHQ

SPLV

SPMO

SPXC

STRA

TMXXF

UDMY

VSTA

WFRD

XMMO

XPRO

Legal

Press Releases

Stride, Inc. Announcement: If You Have Suffered Losses in Stride, Inc. (NYSE: LRN), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

Opening Doors to Healthcare Careers: McKallen Medical Training Center Partners with MedCerts to Expand Access to Training Programs for Aspiring Healthcare Professionals

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Stride, Inc. - LRN

Stride, Inc. Named 2024 Company of the Year by BIG Awards for Business

MedCerts and Nurturing Minds Partner to Deliver Flexible Online Healthcare Training Solutions for Students in Ohio and Nationwide

Stride Inc.'s Kevin P. Chavous Honored with 2024 Profiles in Diversity Journal® Black Leadership Award

Ohio's IMAP Program Offers Full Tuition Coverage for Tech Elevator Coding Bootcamps

K12 Tutoring Launches Nationwide, Empowering Students with Personalized Learning Support

MedCerts and New Hope Training Programs Forge Partnership to Empower Students and Advance Diversity in the Healthcare Workforce

Afya

American Public Education, Inc. - Common Stock

American Public Education

Comments

Stride

Stride (LRN) Forecast

Stride (NYSE:LRN) Stock, Quote.Headers.trade-ideas

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga